President Donald J. Trump officially launched TrumpRx.gov on Thursday, a federal direct-to-consumer website offering steep discounts on dozens of commonly used prescription drugs, fulfilling his pledge to slash medication costs for Americans and bring U.S. prices in line with those paid in other developed nations under the Most-Favored Nation policy.

Trump hailed the launch as a major win for consumers. “America was being overcharged for medicine,” he said. “The same drugs, made in the same factories, at the same dosages, are costing Americans up to 1,000% more than in any other country. This is unacceptable.”

“Starting tonight,” Trump added, “dozens of the most commonly used prescription drugs will be available at dramatic discounts for all consumers throughout our new website, it’s called TrumpRx.gov.”

The initiative is the result of agreements with major pharmaceutical companies including AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with additional drugs and manufacturers expected to be added in the coming months. Patients with valid prescriptions can access savings through printable or mobile coupons or via manufacturer-integrated channels.

Key price reductions include:

  • Ozempic and injectable Wegovy dropping from $1,028 and $1,349 per month to an average of $350 and as low as $199, depending on dosage
  • Wegovy pill reduced from $1,349 to as low as $149
  • Zepbound declining from $1,088 to an average of $346 and as low as $299
  • Fertility drugs Gonal-F, Cetrotide, and Ovidrel reduced to as low as $168, $22.50, and $84 per pen or dose
  • Bevespi Aerosphere (COPD inhaler) cut from $458 to $51
  • Airsupra (asthma inhaler) reduced from $504 to $201
  • Eucrisa (atopic dermatitis ointment) cut from $792 to $158
  • Insulin Lispro reduced to as low as $25 per month
  • Duavee (hot flashes and osteoporosis) reduced from $202 to $30

America’s HealthShare praised the move, calling it a long-overdue step toward affordability. “America’s healthcare system is broken, and people are simply paying too much for medicine and hospital visits,” the organization said. “America’s HealthShare enthusiastically supports the effort to offer working families and elderly people on fixed incomes access to more affordable prescription drugs.”

President David Lejeune added that policymakers should build on the effort. “Our law and policymakers can and should work with this Administration, in bipartisan fashion, to address long-term solutions to America’s healthcare system,” he said. “We are proud to support the Make America Healthy Again movement by restoring freedom and accountability in healthcare.”

The launch of TrumpRx.gov directly fulfills Trump’s promise to end pharmaceutical overcharging, empower consumers, and force industry accountability, marking one of the most aggressive federal actions to date aimed at lowering drug prices for American families.